Liu, Q., Luo, Q., Ju, Y. & Song, G. Role of the mechanical microenvironment in cancer development and progression. Cancer Biol. Med. 17, 282–292 (2020).
Amer, M., Shi, L. & Wolfenson, H. The ‘yin and yang’ of cancer cell growth and mechanosensing. Cancers https://doi.org/10.3390/cancers13194754 (2021).
Lv, J. et al. Cell softness regulates tumorigenicity and stemness of cancer cells. EMBO J. https://doi.org/10.15252/embj.2020106123 (2021).
Fuhs, T. et al. Rigid tumours contain soft cancer cells. Nat. Phys. 18, 1510–1519 (2022).
Lei, K. et al. Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy. Nat. Biomed. Eng. 5, 1411–1425 (2021).
Liu, Y. et al. Cell softness prevents cytolytic T-cell killing of tumor-repopulating cells. Cancer Res. 81, 476–488 (2021).
Tello-Lafoz, M. et al. Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer. Immunity 54, 1037–1054.e1037 (2021).
Zhou, Y. et al. Cell softness renders cytotoxic T lymphocytes and T leukemic cells resistant to perforin-mediated killing. Nat. Commun. 15, 1405 (2024).
Dustin, M. L. & Long, E. O. Cytotoxic immunological synapses. Immunol. Rev. 235, 24–34 (2010).
Finn, O. J. A believer’s overview of cancer immunosurveillance and immunotherapy. J. Immunol. 200, 385–391 (2018).
Basu, R. et al. Cytotoxic T cells use mechanical force to potentiate target cell killing. Cell 165, 100–110 (2016).
Basu, R. & Huse, M. Mechanical communication at the immunological synapse. Trends Cell Biol. 27, 241–254 (2017).
Alibert, C., Goud, B. & Manneville, J. B. Are cancer cells really softer than normal cells? Biol. Cell 109, 167–189 (2017).
Levental, K. R. et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891–906 (2009).
Plodinec, M. et al. The nanomechanical signature of breast cancer. Nat. Nanotechnol. 7, 757–765 (2012).
Tan, Y. et al. Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression. Nat. Commun. 5, 4619 (2014).
Cappell, K. M. & Kochenderfer, J. N. Long-term outcomes following CAR T cell therapy: what we know so far. Nat. Rev. Clin. Oncol. 20, 359–371 (2023).
Brown, C. E. et al. Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N. Engl. J. Med. 375, 2561–2569 (2016).
Sampson, J. H. et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. J. Clin. Oncol. 28, 4722–4729 (2010).
Yu, Z., Pestell, T. G., Lisanti, M. P. & Pestell, R. G. Cancer stem cells. Int. J. Biochem. Cell Biol. 44, 2144–2151 (2012).
Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124–1134 (2017).
Masoumi, J. et al. Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: challenges and prospects. Acta Pharm. Sin. B 11, 1721–1739 (2021).
Liu, L. et al. Engineering chimeric antigen receptor T cells for solid tumour therapy. Clin. Transl. Med. 12, e1141 (2022).
Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 1507–1517 (2014).
Tee, S.-Y., Fu, J., Chen, C. S. & Janmey, P. A. Cell shape and substrate rigidity both regulate cell stiffness. Biophys. J. 100, L25–L27 (2011).
Tse, J. R. & Engler, A. J. Preparation of hydrogel substrates with tunable mechanical properties. Curr. Protoc. Cell Biol. 10, 10.16 (2010).
Liang, C. et al. Towards an integrative understanding of cancer mechanobiology: calcium, YAP, and microRNA under biophysical forces. Soft Matter 18, 1112–1148 (2022).
Jiang, Y. et al. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J. Hematol. Oncol. https://doi.org/10.1186/s13045-022-01252-0 (2022).
Gilbert, S. M. et al. ATP in the tumour microenvironment drives expression of nfP2X(7), a key mediator of cancer cell survival. Oncogene 38, 194–208 (2019).
So, C. L. et al. Increased matrix stiffness suppresses ATP-induced sustained Ca2+ influx in MDA-MB-231 breast cancer cells. Cell Calcium 104, 102569 (2022).
Lembong, J., Sabass, B., Sun, B., Rogers, M. E. & Stone, H. A. Mechanics regulates ATP-stimulated collective calcium response in fibroblast cells. J. R. Soc. Interface 12, 20150140 (2015).
Furlow, P. W. et al. Mechanosensitive pannexin-1 channels mediate microvascular metastatic cell survival. Nat. Cell Biol. 17, 943–952 (2015).
Wang, X. et al. Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase. Oncotarget 8, 87860–87877 (2017).
Jones, C. A. & Hazlehurst, L. A. Role of calcium homeostasis in modulating EMT in cancer. Biomedicines https://doi.org/10.3390/biomedicines9091200 (2021).
Yoon, C. W. et al. Tumour priming by ultrasound mechanogenetics for CAR T therapy. Nat. Mater. 25, 310–321 (2026).
Velez, D. O. et al. 3D collagen architecture induces a conserved migratory and transcriptional response linked to vasculogenic mimicry. Nat. Commun. 8, 1651 (2017).
Fatma, H. & Siddique, H. R. Pluripotency inducing Yamanaka factors: role in stemness and chemoresistance of liver cancer. Expert Rev. Anticancer Ther. 21, 853–864 (2021).
Fillmore, C. M. & Kuperwasser, C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 10, R25 (2008).
Zhang, K. et al. IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells. Br. J. Cancer 130, 1337–1347 (2024).
Costa, R. L. B. & Gradishar, W. J. Triple-negative breast cancer: current practice and future directions. J. Oncol. Pract. 13, 301–303 (2017).
Nelson, R. A., Guye, M. L., Luu, T. & Lai, L. L. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis. Ann. Surg. Oncol. 22, 24–31 (2015).
Hu, J. et al. The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer. Breast Cancer Res. Treat. 200, 23–36 (2023).
Berger, C. et al. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J. Clin. Invest. 118, 294–305 (2008).
Lele, T. P., Brock, A. & Peyton, S. R. Emerging concepts and tools in cell mechanomemory. Ann. Biomed. Eng. 48, 2103–2112 (2020).
Kim, J. W. et al. Molecular recording of calcium signals via calcium-dependent proximity labeling. Nat. Chem. Biol. 20, 894–905 (2024).
O’Neill, B. K. & Laughlin, S. T. Neuronal calcium recording with an engineered TEV protease. ACS Chem. Biol. 13, 1159–1164 (2018).
Marzagalli, M., Fontana, F., Raimondi, M. & Limonta, P. Cancer stem cells—key players in tumor relapse. Cancers https://doi.org/10.3390/cancers13030376 (2021).
Ghasemi, K. & Ghasemi, K. A brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies. Eur. J. Pharmacol. https://doi.org/10.1016/j.ejphar.2021.174593 (2022).
Meumann, N. et al. Hepatocellular carcinoma is a natural target for adeno-associated virus (AAV) 2 vectors. Cancers https://doi.org/10.3390/cancers14020427 (2022).
Ito, M., Takino, N., Nomura, T., Kan, A. & Muramatsu, S. I. Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies. Sci. Rep. 11, 9322 (2021).
Rosenblum, D. et al. CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy. Sci. Adv. https://doi.org/10.1126/sciadv.abc9450 (2020).
Jardin, I. et al. Store-operated calcium entry and its implications in cancer stem cells. Cells https://doi.org/10.3390/cells11081332 (2022).
Wu, Y. et al. Control of the activity of CAR-T cells within tumours via focused ultrasound. Nat. Biomed. Eng. 5, 1336–1347 (2021).